Presidio Pharmaceuticals

Developer of small-molecule antiviral therapeutics

placeSan Francisco, California, United States calendar_todayFounded 2006 groups12 employees language presidiopharma.com

Innovation

17 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 968 times.

YearFilings
201211
20139
20148
20157
20164
20174
20181
20201
20211

Investor mix

8 investors on record; lead investors include New Leaf Venture Partners.

Investor typeCountShare
Venture capital450%
Private equity338%
Other / undisclosed113%
Coming soon